dr steven pearson: icer can provide more information when a drug is approved with limited data
Published 5 years ago • 164 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:29
dr steven pearson outlines the goals of icer's drug assessment program
-
51:22
understanding icer: an interview with founder dr. steven pearson
-
11:44
steven pearson of icer discusses a drug's effect on disparities
-
2:01
steven pearson, md, addresses formulary decision making
-
3:28
the story of icer, featuring founder steve pearson (with captions)
-
4:49
daily aspirin - should you take it? cardiologist explains.
-
6:52
aspirin should not be used as a longevity supplement
-
2:49
from dr. steven ashby, director
-
1:37
aspirin shown to fight prostate cancer
-
2:21
many patients face no relief from crippling disease
-
56:28
policy measures on drug value: does icer's approach improve patient access & equity?
-
4:11
ronald pearl, md, phd: chairman of anesthesiology, perioperative and pain medicine
-
2:13
cleveland clinic prostate cancer discovery
-
1:57
meet your provider, dr. jeffrey scow, penn state health milton s. hershey medical canter
-
1:02:41
covid-19: iv drug compatibility and central access
-
1:10
u.s. drug prices: a better way to set the right price
-
1:25
novel detection system for prognosis of cns diseases: unveiling the ev neuro assay
-
1:18
novel agents and precision medicine in prostate cancer care
-
3:12
pearls to identify sepsis in emergency medicine
-
35:30
petrie-flom center's eighth annual health law year in p/review: challenges in drug pricing
-
8:22
prostate cancer research: updates from asco 2023
-
0:46
ep. 7 | colorectal liver metastases treatment by prof. clavien at privatklinik bethanien